Imatinib-associated bilateral gynecomastia and unilateral testicular hydrocele in male patient with metastatic gastrointestinal stromal tumor: A literature review

Journal of Oncology Pharmacy Practice

Volumn 18, Issue 2, 2012, Pages 303-310

  Tanriverdi, Ozgur ^a   Unubol, Mustafa ^a   Taskin, Fisun ^a   Meydan, Nezih ^a   Sargin, Gokhan ^a   Guney, Engin ^a   Barutca, Sabri ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

drug related gynecomastia; gastrointestinal stromal tumor; Imatinib; male mastoplasia; testicular hydrocele

Indexed keywords

ACETYLSALICYLIC ACID; CD34 ANTIGEN; CREATININE; ESTRADIOL; ESTROGEN; FOLLITROPIN; IMATINIB; LUTEINIZING HORMONE; METOPROLOL SUCCINATE; PROGESTERONE; PROLACTIN; STEM CELL FACTOR RECEPTOR; SUNITINIB; TESTOSTERONE;

AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE CLEARANCE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FAMILY HISTORY; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; GYNECOMASTIA; HEART INFARCTION; HEMATEMESIS; HUMAN; HYDROCELE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MEDICAL HISTORY; METASTASIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROTEIN URINE LEVEL; REVIEW; TESTOSTERONE BLOOD LEVEL;

AGED; ANTINEOPLASTIC AGENTS; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; GYNECOMASTIA; HUMANS; MALE; PIPERAZINES; PYRIMIDINES; TESTICULAR HYDROCELE;

EID: 84871734237     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/1078155211424629     Document Type: Review

References (16)

1. Kim H, Chang HM, Ryu MH, Kim TW, Sohn HJ, Kim SE, et al. Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor. J Korean Med Sci. 2005 ; 20 (3). 512-515
2. Gambacorti-Passerini C, Tornaghi L, Cavagnini F, Rossi P, Pecori-Giraldi F, Mariani L, et al. Gynecomastia in men with chronic myeloid leukemia after imatinib. Lancet. 2003 ; 361 (9373). 1954-1956
3. Mughal TI, Schrieber A. Principal long-term adverse effect of imatinib in patients with chronic myeloid leukemia in chronic phase. Biol Targets Ther. 2010 ; 4: 315-323
4. Elliott MA, Mesa RA, Tefferi A. Adverse events after imatinib mesylate therapy. N Engl J Med. 2002 ; 346 (9). 712-713
5. Carlson HE. Approach to the patient with gynecomastia. J Clin Endocrinol Metab. 2011 ; 96 (1). 15-21
6. Thompson DF, Carter JR. Drug-induced gynecomastia. Pharmacotherapy. 1993 ; 13 (1). 37-45
7. Murray NP, Daly MJ. Gynecomastia and heart failure - adverse drug reaction or disease process?. Pharm Ther. 1991 ; 16 (4). 275-279
8. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 ; 30 (2). 239-245
9. Zhao D, Wang G, Li C, Meng L. Bilateral masculine mastoplasia associated with imatinib mesylate: a case report and literature review. J Huazhong Univ Sci Technol Med Sci. 2011 ; 31 (1). 145-146
10. Basciani S, Mariani S, Arizzi M, Ulisse S, Rucci N, Jannini EA, et al. Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and -beta during human testicular development and disease. J Clin Endocrinol Metab. 2002 ; 87 (5). 2310-2319
11. Huang CT, Weitsman SR, Dykes BN, Magoffin DA. Stem cell factor and insulin-like growth factor-I stimulate luteinizing hormone - independent differentiation of rat ovarian theca cells. Biol Reprod. 2001 ; 64 (2). 451-456
12. Brennan J, Tilmann C, Capel B. PDGFR-alpha mediates testis cord organization and fetal Leydig cell development in the XY gonad. Genes Dev. 2003 ; 17 (6). 800-810
13. Prasad AM, Ramnarayan K, Bairy KL. Effect of imatinib on histological parameters in male Swiss albino mice. Int J Pharma Sci Rev Res. 2010 ; 4 (2). 117-122
14. Lodish MB, Stratakis CA. Endocrine side effects of broad-acting kinase inhibitors. Endocr Relat Canc. 2010 ; 17 (3). 233-244
15. Ballardini P, Marguitti G, Aliberti C, Manfredini R. Onset of male gynecomastia in a patient treated with sunitinib for metastatic renal cell carcinoma. Clin Drug Invest. 2009 ; 29 (7). 487-490
16. Caocci G, Atzeni S, Orru N, Azzena L, Martorana L, Littera R, et al. Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia. Leukemia. 2008 ; 22 (11). 2127-2128